Gordon John Freund

Affiliations

  • Director at Collegium Pharmaceutical Inc (COLL), 2025-06-11
  • at Si-Bone Inc. (SIBN), 2025-06-06
  • at Sutro Biopharma Inc. (STRO), 2024-06-10
  • Director at Tetraphase Pharmaceuticals Inc (TTPH), 2019-12-13
  • Director at Proteon Therapeutics Inc (PRTO), 2019-11-12
  • Director at Xenoport Inc (XNPT), 2016-07-07
  • Other at Dicerna Pharmaceuticals Inc (DRNA), 2015-02-25
  • Large Shareholder at Acelrx Pharmaceuticals Inc (ACRX), 2014-03-12
  • Large Shareholder, Director at Concert Pharmaceuticals Inc. (CNCE), 2014-02-21
  • Director at Mako Surgical Corp. (MAKO), 2013-12-17
  • Large Shareholder, Director at Map Pharmaceuticals Inc. (MAPP), 2011-05-24
  • Director at Hansen Medical Inc (HNSN), 2009-04-21
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SIBN $15.00 325,000 $4,875,000.00 4,419,985 2018-10-19 Filing
COLL $12.00 150,000 $1,800,000.00 2,949,916 2015-05-12 Filing
PRTO $10.00 200,000 $2,000,000.00 200,000 2014-10-27 Filing
XNPT $3.93 12,500 $49,163.75 22,633 2014-06-03 Filing
XNPT $3.72 9,500 $35,354.25 21,200 2014-05-23 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
COLL $30.62 6,601 $202,149.02 70,658 2025-06-09 Filing
SIBN $20.54 30,000 $616,197.00 103,899 2023-08-09 Filing
SIBN $31.41 12,591 $395,426.65 331,366 2021-06-16 Filing
SIBN $31.11 21,511 $669,136.22 343,957 2021-06-15 Filing
SIBN $31.28 17,990 $562,737.99 365,468 2021-06-14 Filing